Vaxcyte closes USD 650 million convertible senior notes offering
Bitget2026/10/09 20:06Vaxcyte closed a USD 575 million offering of 1.50% convertible senior notes due 2032. Underwriters fully exercised an option to buy an additional USD 75 million of notes to cover over-allotments. Gross proceeds from the concurrent equity, warrant, and note offerings totaled about USD 1.15 billion. Net proceeds earmarked for VAX-31 clinical development, manufacturing scale-up, and launch preparation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610091605PRIMZONEFULLFEED9843160) on October 09, 2026, and is solely responsible for the information contained therein.
- Vaxcyte closed a USD 575 million offering of 1.50% convertible senior notes due 2032.
- Underwriters fully exercised an option to buy an additional USD 75 million of notes to cover over-allotments.
- Gross proceeds from the concurrent equity, warrant, and note offerings totaled about USD 1.15 billion.
- Net proceeds earmarked for VAX-31 clinical development, manufacturing scale-up, and launch preparation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
United States Dollar Index remains subdued as lower oil prices ease inflation pressure
Silver Price Forecast: XAG/USD rises to near $53.00 as lower oil eases inflation pressure
Crypto prices
More
